TERN position history
The shares of Terns Pharmaceuticals (TERN) that DAVIDSON KEMPNER CAPITAL MANAGEMENT LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 311,623 shares, $16M, 0.22% of portfolio, New
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|